Ingredients

(Image: Getty/Светлана Зайцева)

US farm bill a boon for pharma?

By Flora Southey

If approved by President Trump, the five-year farm bill – which removes hemp from the federal controlled substance list – could help advance cannabinoid R&D, says Nexien Biopharma.

Getty/Ninitta

Significant step taken towards insulin pill

By Ben Hargreaves

Researchers from Harvard University have developed an insulin formulation using two ionic liquids they say could lead to the development of a pill for diabetics.

(Image: Getty/Sinhyu)

First product derived from cannabis given US FDA nod

By Ben Hargreaves

UK-based GW Pharmaceuticals has been given marketing approval by the US FDA for its product, Epidiolex, to be used for the treatment of two severe forms of epilepsy – Lennox-Gastaut syndrome and Dravet syndrome.

Follow us

Products

View more

Webinars